Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Penny Stocks

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • News
  • Penny Stocks

– Soligenix Announced HyBryte Phase 3 FLASH Study for the Treatment of Cutaneous T-Cell Lymphoma Published in JAMA Dermatology; Published Findings Demonstrate that HyBryte Treatment Statistically Significantly Reduced CTCL Lesion Size

By Charles Gross
July 20, 11:20 AM
Soligenix, Inc.

SNGX

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

Soleno Shares Surge On Regulatory Update For Its Prader-Willi Syndrome Hopeful

By Vandana Singh
July 20, 10:59 AM
Soleno Therapeutics Inc (NASDAQ:SLNO) provided an update following recent communications with the FDA regarding the development of once-daily DCCR (diazoxide choline)…

SLNO

Read More
1 minute read
  • Movers
  • Penny Stocks
  • Trading Ideas

Why Shares Of Soleno Therapeutics Are Trading Higher

By Happy Mohamed
July 20, 10:38 AM
Shares of small-cap penny stock Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares are trading higher after the company provided a regulatory update following recent communications with the FDA regarding the development of DCCR for the treatment of Prader-Willi syndrome.

SLNO

Read More
1 minute read
  • Movers
  • Penny Stocks
  • Trading Ideas

Why Shares Of Small-Cap Cannabis Company Are Trading Higher

By Happy Mohamed
July 20, 10:26 AM
Shares of small-cap penny stock Greenlane Holdings, Inc. (NASDAQ: GNLN) shares are trading higher after the company announced the sale of its stake in VIBES Holdings LLC for $5.3 million in cash.

GNLN

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks

Heritage Cannabis Launching Social Responsibility Program – Heritage Helps

By Vuk Zdinjak
July 20, 9:00 AM
Heritage Cannabis Holdings Corp. (OTCQX: HERTF) (CSE:CANN) is launching Heritage Helps, a new program embraced by management, employees and stakeholders that will be introduced throughout 2022.

CSE:CANN

Read More
2 minute read
  • Biotech
  • Exclusives
  • General
  • Health Care
  • News
  • Penny Stocks

EXCLUSIVE: Adial Pharma’s AD04 Effective In Heavy Drinker Alcohol Use Disorder Patients

By Vandana Singh
July 20, 6:45 AM
Adial Pharmaceuticals Inc's (NASDAQ: ADIL) ONWARD Phase 3 study of AD04 for Alcohol Use Disorder (AUD) achieved a statistically significant mean reduction in heavy drinking days compared to placebo.

ADIL

Read More
5 minute read
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Small Cap
  • Trading Ideas

Why Crypto-Related Companies Traded Higher; Here Are 72 Biggest Movers From Yesterday

By Lisa Levin
July 20, 3:59 AM
Gainers Applied Blockchain, Inc. (NASDAQ: APLD) shares climbed 100% to close at $2.12 on Tuesday after the company reported a 200-megawatt five-year hosting contract with Marathon Digital Holdings and raised its Q4 revenue forecast.

AEZS

Read More
4 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • News
  • Penny Stocks
  • Small Cap

Recap of Tuesday’s Biotech Catalysts – End Of The Day Summary

By Ragothaman Srinivasan
July 19, 6:11 PM
The U.S. Food and Drug Administration (FDA) has granted tentative approval to Avadel Pharmaceuticals’ (NASDAQ: AVDL) lead candidate LUMRYZ (FT218) for the treatment of excessive daytime sleepiness (EDS) or cataplexy in adults with narcolepsy.

ALNA

Read More
1 minute read
  • Movers
  • Penny Stocks
  • Trading Ideas

Camber Energy Shares Are Popping Off Today: What’s Happening?

By Henry Khederian
July 19, 3:56 PM
Camber Energy Inc (NASDAQ: CEI) shares are trading sharply higher by 13.70% to $0.43 Tuesday.

CEI

Read More
2 minute read
  • Cannabis
  • Markets
  • Penny Stocks
  • Psychedelics

Two Psychedelic Companies File Patent Applications For Psilocybin And MDMA Analogues, Here’s What Could Change

By Lara Goldstein
July 19, 3:51 PM
Mydecine (OTC: MYCOF) and Lobe Sciences (OTCQB: LOBEF), two companies in the psychedelics space, have filed patent applications.

LOBEF

Posts pagination

Previous 1 … 1,195 1,196 1,197 … 1,231 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service